FDA Approves Sanofiís Auvi-Q Auto-Injector

by Kathy Jones on  August 14, 2012 at 7:14 PM General Health News
RSS Email Print This Page Comment
Font : A-A+

French pharmaceutical giant Sanofi SA said that the US Food and Drug Administration has approved its epinephrine auto-injector that provides users with audio and written instructions about going through their treatment for allergic reaction.
 FDA Approves Sanofiís Auvi-Q Auto-Injector
FDA Approves Sanofiís Auvi-Q Auto-Injector

Marketed under the brand name Auvi-Q, the injection contains hormone epinephrine and is the first such product to be approved by the FDA.

The company said that Auvi-Q comes with a training device, a retractable needle mechanism to limit accidental needle sticks and an alert light to inform the user when injection is complete.

"As a company committed to patient-centered care, our focus is on creating innovative solutions that make a difference in the lives of people. Auvi-Q delivers on this by offering a state-of-the-art epinephrine auto-injector device that addresses the needs of patients at risk for life-threatening allergic reactions and their caregivers", Sanofi's Anne Whitaker said.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive